Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 29, 2011British Journal of PharmacologyOpen Access

Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis‐like disease in C57BL/6 mice

View Full Paper
Ask AI
Bookmark
Share

Authors

EKEwa KozelaWeizmann Institute of ScienceNLNirit LevTel Aviv UniversityNKNathali KaushanskyWeizmann Institute of Science

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kozela et al. (2011) studied this question.

synapsesocial.com/papers/6a03436fc8c4199b329e447ehttps://doi.org/10.1111/j.1476-5381.2011.01379.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epitope Specificity of Autoreactive T and B Cells Associated with Experimental Autoimmune Encephalomyelitis and Optic Neuritis Induced by Oligodendrocyte-Specific Protein in SJL/J Mice2006 · 31 citations
  2. 2Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis2003 · 309 citations
  3. 3Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption2007 · 211 citations